ArticleNature biotechnology2022
CRISPR comes a-knock-in to reprogram antibodies in vivo.
Harald Hartweger et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleNature biotechnology2022
Harald Hartweger et al.PubMed ↗Publisher ↗
No numbers read from the abstract.